anaveon
  • About
    • Our Journey
    • About Us
    • Anaveon In Depth
  • Science
    • Our Approach
    • Publications
  • Team
    • Our Team
    • Our Board
    • Our Investors
  • News
  • Career
  • Contact Us
Select Page
HomeApril
Anaveon Announces Appointment of Dr Allison Jeynes-Ellis to its Board of Directors

Anaveon Announces Appointment of Dr Allison Jeynes-Ellis to its Board of Directors

by admin | Apr 10, 2019 | Press Releases

Anaveon, an immuno-oncology company, today announced that it has appointed Dr Allison Jeynes-Ellis to its Board of Directors.

Search here

Categories

  • News 1
  • Press Releases 9

Recent Posts

  • Anaveon presents compelling data from the Phase I/II study of ANV419 during the AACR Annual Meeting 2022
    April 11, 2022
  • Anaveon to present first clinical data from the Phase I/II study of ANV419 at the AACR Annual Meeting 2022
    March 9, 2022
  • Anaveon_ gloved hand in laboratoryAnaveon to raise CHF 110 million in oversubscribed Series B financing
    December 16, 2021

We are social

Popular Tags

2020 AACR Annual Meeting anaveon brand clinical data CTA approval First patient investment news phase I phase I/II study phase II presentation press start trial study data team website

Archives

  • April 2022  1
  • March 2022  1
  • December 2021  1
  • November 2021  1
  • June 2021  1
  • March 2021  1
  • November 2020  1
  • May 2020  1
  • April 2019  1
  • February 2019  1
Anaveon_ submark

Contact us

Email

contact@anaveon.com

Postal Address

Anaveon AG

Technologiepark Basel

Hochbergerstrasse 60C

4057 Basel

Switzerland

Follow us

  • Linkedin
  • Home
  • Privacy Policy
  • Photography Credit

© 2020 All Rights Reserved